e-Article
A 1-year pilot study of intralymphatic injections of GAD-alum in individuals with latent autoimmune diabetes in adults (LADA) with signs of high immunity: No safety concerns and resemblance to juvenile type 1 diabetes
Document Type
Artikel
Author
Source
Diabetes, obesity & metabolism. 25(11):3400-3409
Subject
Language
English
English
English
ISSN
1463-1326